Showing results (101-110 of 125) with videos related to
Sort By:
Pageof 13
Heart (British Cardiac Society)|August 7, 2012
Direct comparison of mid-regional pro-atrial natriuretic peptide with N-terminal pro B-type natriuretic peptide in the diagnosis of patients with atrial fibrillation and dyspnoeaJens Eckstein, Mihael Potocki, Karsten Murray, et al.Critical Care (London, England)|July 25, 2009
Midregional pro-adrenomedullin in addition to b-type natriuretic peptides in the risk stratification of patients with acute dyspnea: an observational studyMihael Potocki, Tobias Breidthardt, Tobias Reichlin, et al.Journal of the American College of Cardiology|July 13, 2010
Prognostic value of mid-regional pro-adrenomedullin levels taken on admission and discharge in non-ST-elevation myocardial infarction: the LAMP (Leicester Acute Myocardial Infarction Peptide) II studyOnkar S Dhillon, Sohail Q Khan, Hafid K Narayan, et al.Annals of Neurology|December 26, 2009
Copeptin: a novel, independent prognostic marker in patients with ischemic strokeMira Katan, Felix Fluri, Nils G Morgenthaler, et al.European Journal of Heart Failure|March 11, 2010
Mid-regional pro-adrenomedullin as a novel predictor of mortality in patients with chronic heart failureStephan von Haehling, Gerasimos S Filippatos, Jana Papassotiriou, et al.Circulation|May 5, 2010
Plasma copeptin and the risk of diabetes mellitusSofia Enhörning, Thomas J Wang, Peter M Nilsson, et al.JAMA|July 2, 2009
Novel and conventional biomarkers for prediction of incident cardiovascular events in the communityOlle Melander, Christopher Newton-Cheh, Peter Almgren, et al.Stroke|August 30, 2014
Copeptin for the prediction of recurrent cerebrovascular events after transient ischemic attack: results from the CoRisk studyGian Marco De Marchis, Anja Weck, Heinrich Audebert, et al.Journal of the American College of Cardiology|June 27, 2009
Incremental value of copeptin for rapid rule out of acute myocardial infarctionTobias Reichlin, Willibald Hochholzer, Claudia Stelzig, et al.Plos One|January 26, 2011
Identification of chronic heart failure patients with a high 12-month mortality risk using biomarkers including plasma C-terminal pro-endothelin-1Ewa A Jankowska, Gerasimos S Filippatos, Stephan von Haehling, et al.Pageof 13